-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Neurocrine Biosciences Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Neurocrine Biosciences Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $130M, a 56.2% increase year-over-year.
- Neurocrine Biosciences Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $386M, a 102% increase year-over-year.
- Neurocrine Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2023 was $250M, a 61.6% increase from 2022.
- Neurocrine Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2022 was $155M, a 72.4% increase from 2021.
- Neurocrine Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2021 was $89.6M, a 78% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)